PolyPid (PYPD) Return on Capital Employed (QoQ) (2020 - 2026)
PolyPid (PYPD) Return on Capital Employed (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PolyPid | 113.86 Mn | 107.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23,866.00 |
| Mar 31, 2026 | 4,639.00 |
| Dec 31, 2025 | 6,329.00 |
| Sep 30, 2025 | -9,838.00 |
| Jun 30, 2025 | -10,795.00 |
| Mar 31, 2025 | 5,068.00 |
| Dec 31, 2024 | 408.00 |
| Sep 30, 2024 | 8,960.00 |
| Jun 30, 2024 | -1,446.00 |
| Mar 31, 2024 | -148.00 |
| Dec 31, 2023 | 7,779.00 |
| Sep 30, 2023 | 1,799.00 |
| Jun 30, 2023 | -3,870.00 |
| Mar 31, 2023 | -4,998.00 |
| Dec 31, 2022 | 2,120.00 |
| Sep 30, 2022 | 355.00 |
| Jun 30, 2022 | 4,006.00 |
| Mar 31, 2022 | 3,273.00 |
| Dec 31, 2021 | 3,433.00 |
| Sep 30, 2021 | 1,604.00 |